solver.press

Quantum sampling architectures (QSAD) for protein structure reconstruction will exhibit power-law scaling of conformational search efficiency when constrained by the same exponent-range precision barrier governing FP32-BF16 loss-landscape mismatch (LMC) in surrogate Bayesian optimization, with the barrier magnitude inversely proportional to the number of qubits in the quantum-classical hybrid system.

QuantumAug 2, 2026Evaluation Score: 61%

Quantum sampling architectures (QSAD) for protein structure reconstruction will exhibit power-law scaling of conformational search efficiency when constrained by the same exponent-range precision barrier governing FP32-BF16 loss-landscape mismatch (LMC) in surrogate Bayesian optimization, with the barrier magnitude inversely proportional to the number of qubits in the quantum-classical hybrid system.

Adversarial Debate Score

45% survival rate under critique

Expert panel critique

Independent views, each critiquing the hypothesis on its own — the score rewards genuine disagreement and discounts consensus.

Gemini: 5/10 Strengths: The hypothesis correctly aligns with validated findings that exponent-range precision barriers (FP32-BF16) govern loss-landscape mismatch (LMC) and scale down via a power law as model capacity increases. Weaknesses: The assumption that the barrier magnitude is inverse...
Mistral: The hypothesis is ambitious and grounded in validated findings (e.g., exponent-range LMC barriers, power-law scaling), but it relies on refuted premises (BF16 capacity, noise-sharpening) and lacks direct empirical support from the owner’s experiments for the proposed quantum-classical hybrid scal...
ChatGPT: The hypothesis is nominally falsifiable and borrows from the validated power-law FP32–BF16 LMC result, but it makes an unsupported category leap from model parameter count and numerical exponent range to qubit count and QSAD conformational-search efficiency. None of the cited excerpts or validate...
Claude: The hypothesis's core mechanistic claim — that the FP32-BF16 LMC barrier governs quantum sampling efficiency in QSAD — is unsupported by any validated experimental linkage between precision arithmetic barriers and qubit-count scaling, and critically, the validated power-law finding (barrier ∝ par...

Supporting Research Papers

Literature Assessment

📖 Literature-assessed (LLM)· literature_meta

An LLM's reading of the literature — not computational verification.

Quantum sampling may enhance protein structure reconstruction efficiency.

Method: literature_meta · Result: inconclusive

Formal Verification

Z3 logical consistency:✅ Consistent

Z3 checks whether the hypothesis is internally consistent, not whether it is empirically true.

Experimental Validation Package

This discovery has a Claude-generated validation package with a full experimental design.

Precise Hypothesis

Quantum sampling architectures for protein-structure conformational search (QSAD) exhibit conformational-search-efficiency scaling of the form E(Q) ∝ Q^(-α), where Q is qubit count and α is a scaling exponent, and the same numerical exponent range (α) that characterizes the FP32→BF16 precision loss-mismatch (LMC) barrier in classical surrogate Bayesian optimization also bounds α in the quantum system. Specifically: (1) there exists a measurable "precision barrier" B(Q) in QSAD sampling efficiency analogous in functional form to the exponent-range mismatch B(bits) observed between FP32 and BF16 surrogate loss landscapes; (2) B(Q) ∝ 1/Q across at least a 2-order-of-magnitude range of qubit counts (e.g., 10–1000 logical/effective qubits, simulated or physical); (3) this relationship is falsifiable by fitting B(Q) vs Q on log-log axes and testing whether the fitted exponent differs significantly (p<0.05, bootstrap CI excludes 0) from an inverse (exponent = -1 ± 0.15) proportionality.

Disproof criteria:
  • If fitted log-log slope of B(Q) vs Q falls outside [-1.15, -0.85] with 95% CI excluding -1, the inverse-proportionality claim is disproved.
  • If no statistically significant power-law fit exists (R² < 0.5 on log-log regression, or Akaike weight for power-law model < 0.3 relative to exponential/flat null models), disproof of power-law scaling.
  • If the FP32-BF16 LMC exponent measured independently in the classical surrogate optimizer does not correlate (Pearson |r| < 0.3, p>0.05) with the quantum barrier exponent across ≥5 independent problem instances, the cross-domain "same barrier" claim is disproved.
  • If quantum sampling efficiency scaling is dominated by noise/decoherence artifacts rather than qubit count (verified via noise-ablation control runs), the mechanism claim is disproved even if a correlation is superficially observed.

Spine & Adversarial ReadReady for validation

This hypothesis tests whether the scaling exponent governing conformational-search efficiency in qubit-count-varying quantum-classical hybrid protein-folding samplers is statistically indistinguishable from the scaling exponent governing the FP32-BF16 precision-mismatch barrier in classical surrogate Bayesian optimization.

  • highThe premise that a well-characterized 'FP32-BF16 LMC exponent-range precision barrier' exists as an established, reproducible phenomenon in classical surrogate Bayesian optimization is unsupported by any citation or dataset in the provided materials — the entire hypothesis may be anchoring to an undefined or non-existent baseline quantity.
    Not resolved in this EVP. Phase A of the protocol requires independently establishing/reproducing this baseline before any cross-domain comparison is meaningful; this is flagged as Abort Checkpoint Day 15. If the LMC claim cannot be sourced or reproduced, the hypothesis is untestable as stated and must be reformulated as a purely quantum-side scaling-law study.
  • highWhy HP lattice models and QAOA/VQE specifically, rather than e.g. quantum annealing, more realistic coarse-grained force fields, or classical replica-exchange MD as the comparator? The methodology choice is not justified against alternatives that might show the same or opposite scaling behavior, risking a result that is an artifact of the specific (convenient, easy-to-simulate) model choice rather than a general physical law.
    Partially addressed: HP lattice models are chosen because they admit exact/brute-force ground truth at small sizes (needed for the efficiency metric) and are standard benchmarks in quantum-folding proof-of-concept literature. However, the EVP does not include a control comparing against quantum annealing (D-Wave-style) or classical replica-exchange MD baselines, which would test whether the scaling law is specific to the QAOA/VQE ansatz class or a more general property of hybrid sampling. This is a gap — recommend adding a comparator arm before treating any positive result as evidence of a general law rather than an ansatz-specific one.
  • mediumWith only 4 primary qubit-count conditions and known QAOA-optimization non-convexity/barren-plateau issues at larger qubit counts, any observed power-law fit is at high risk of being a low-power, small-n curve-fitting artifact rather than a genuine scaling law, especially given the documented tendency of variational quantum algorithms to fail to show scaling advantage in independently replicated studies.
    Partially resolved via the hold-out replication step (independent qubit counts 15/30/60) and bootstrap CIs, but the underlying statistical power problem is real and not fully solved by n=4-7 conditions. Recommend escalating to at least 8-10 qubit-count conditions and pre-registering the analysis (including AIC model comparison against stretched-exponential and logarithmic alternatives) before claiming power-law confirmation, to guard against the barren-plateau phenomenon being misread as favorable scaling.

Experimental Protocol

Minimum viable test (MVT): (1) Implement a small hybrid QAOA/VQE-based conformational sampler on a lattice HP-model protein (20–48 monomers) using Qiskit/PennyLane simulators at 4 qubit counts (10, 20, 40, 80 logical qubits via tensor-network simulation). (2) Implement a matched classical Bayesian optimization surrogate (Gaussian process or BoTorch) operating on the same discretized conformational space, run at FP32 and BF16 precision to measure the LMC exponent independently. (3) For each qubit count, measure conformational search efficiency (e.g., number of oracle calls to reach within 5% of known ground-state energy, or Pearson correlation of sampled energy distribution to exact diagonalization baseline for small instances). (4) Fit power laws to both datasets; compare exponents statistically. (5) Repeat with 3 random seeds × 3 problem instances per qubit count to obtain variance estimates.

Required datasets:
  • Synthetic HP-model / lattice protein benchmark set (20–100 monomer sequences; standard benchmark sequences from Unger & Moult, Berger & Leighton lattice folding literature).
  • Small real protein fragments with known structures for validation (e.g., Trp-cage, villin headpiece — PDB 1L2Y, 1YRF) discretized to coarse-grained torsion-angle bins.
  • Exact diagonalization / brute-force ground truth for small instances (≤30 monomers) as reference efficiency baseline.
  • Classical Bayesian optimization surrogate training logs (loss landscapes) at FP32 vs BF16 precision — reuse or regenerate the LMC benchmark referenced in the discovery's own prior work (needs explicit citation/dataset from that "FP32-BF16 LMC" study, not provided in materials — must be sourced or re-derived).
  • Quantum simulation backends: Qiskit Aer (statevector + tensor-network MPS simulator), PennyLane + Lightning-GPU, optionally IBM Quantum or IonQ hardware access for small qubit-count validation runs.
  • Compute environment: GPU-accelerated tensor-network simulators (cuQuantum/cuTensorNet) for 40–80 qubit approximate simulation.
Success:
  • Power-law fit R² ≥ 0.85 for quantum efficiency vs Q across ≥4 qubit-count conditions.
  • Fitted exponent 95% CI overlaps with independently measured classical LMC exponent CI (overlap criterion) in ≥3 of 5 tested problem instances.
  • Noise-ablation control confirms scaling is not fully explained by noise (partial correlation of Q with efficiency remains significant, p<0.05, after controlling for noise level).
  • Effect replicates in independent hold-out qubit-count range with same-sign, same-order-of-magnitude exponent (within ±0.3 of discovery-set exponent).
Failure:
  • Power-law R² < 0.5, or exponential/logarithmic model preferred by AIC.
  • No significant correlation (|r|<0.3, p>0.05) between quantum and classical exponents across instances.
  • Effect vanishes or reverses sign under noise ablation (i.e., artifact of simulator noise model, not qubit count).
  • Hold-out replication fails to reproduce exponent sign or order of magnitude.

4,200

GPU hours

120d

Time to result

$45,000

Min cost

$260,000

Full cost

ROI Projection

Commercial:

Moderate-to-speculative near-term commercial value; primary value is as a decision-support/triage tool for quantum computing vendors (IBM, IonQ, Rigetti, Google Quantum AI) and pharma quantum-computing partnerships (e.g., quantum-for-drug-discovery consortia) to avoid wasted hardware-access spend. Also valuable as a methodological contribution bridging ML numerical-precision research (BF16/FP32 training stability, relevant to any AI drug-discovery shop, including the MS transcriptomics target-scoring pipeline described in context, which itself could benefit from precision-aware surrogate scoring) and quantum algorithm design. Low direct near-term revenue potential; primarily strategic/positioning value and publication value (Nature Quantum Information / npj Quantum Information tier).

TIME_TO_RESULT_DAYS: 120

Implementation Sketch

# Phase A: Classical LMC baseline
for precision in [FP32, BF16]:
    surrogate = GaussianProcessSurrogate(precision=precision)
    loss_landscape = surrogate.fit(conformational_energy_dataset)
    lmc_deviation[precision] = compare_landscape(loss_landscape, FP32_reference)
lmc_exponent = fit_power_law(lmc_deviation_vs_bitwidth_proxy)

# Phase B: Quantum-classical hybrid sampler
for Q in [10, 20, 40, 80]:
    for seed in [1,2,3]:
        for instance in benchmark_sequences:
            ansatz = build_QAOA(num_qubits=Q, cost_hamiltonian=encode(instance))
            result = hybrid_optimize(ansatz, classical_optimizer=COBYLA, backend=tensor_network_sim)
            efficiency[Q][seed][instance] = oracle_calls_to_convergence(result, exact_baseline[instance])

quantum_exponent = fit_power_law(efficiency vs Q, log_log=True)

# Phase C: Cross-domain comparison
compare_CI_overlap(quantum_exponent, lmc_exponent)
run_noise_ablation(Q_range, noise_levels=[0, 0.01, 0.05])
run_holdout_replication(Q_holdout=[15,30,60])
Abort checkpoints:
  • Day 15: If Phase A (classical LMC baseline reproduction) cannot itself be reliably measured or the source LMC claim cannot be operationally defined/reproduced, abort — the whole hypothesis is contingent on this being a real, well-defined quantity.
  • Day 35: If exact-diagonalization baselines for ≤30-monomer instances cannot be computed within compute budget (e.g., combinatorial blowup), abort or rescale problem sizes.
  • Day 60: If quantum efficiency vs Q data (first 2 qubit-count conditions) shows R²<0.3 for any monotonic trend, abort before committing to remaining qubit-count/hardware runs.
  • Day 90: If noise-ablation control shows scaling is fully explained by noise level (not qubit count), abort before final replication phase.

NAMED_EXPERTS: []

CLOSEST_EXISTING_WORK: []

NOVELTY_NARROWING_REQUIRED: false

Source

AegisMind Research
Need AI to work rigorously on your problems? AegisMind uses the same multi-model engine for personal and professional use. Get started